Radcliffe Capital Management’s Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFYS.WS Stock Holding History

Radcliffe Capital Management’s Portfolio NFYS.WS Stock Details NFYS.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-858,615	Closed	-$40.8K	–	156
2023 Q4	$40.8K	Sell	858,615 -378,885	-31%	-$17.3K	0.01%	123
2023 Q3	$94.4K	Hold	1,237,500	–	–	0.01%	193
2023 Q2	$57.9K	Hold	1,237,500	–	–	﹤0.01%	251
2023 Q1	$158K	Hold	1,237,500	–	–	0.01%	289
2022 Q4	$12.4M	Hold	1,237,500	–	–	0.39%	30
2022 Q3	$12.1M	Hold	1,237,500	–	–	0.29%	35
2022 Q2	$11.9M	Hold	1,237,500	–	–	0.27%	35
2022 Q1	$11.9M	Hold	1,237,500	–	–	0.27%	33
2021 Q4	$11.9M	Buy	+1,237,500	New	+$642K	0.31%	31

Other funds holding NFYS.WS

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

CSD

Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

Radcliffe Capital Management's NFYS.WS Position: Q1 2024 in Review

Radcliffe Capital Management sold out of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) in Q1 2024, closing a stake of 858,615 shares — an estimated $40.8K sold.

Radcliffe Capital Management first reported a position in NFYS.WS in Q4 2021 and held it in 9 quarters. The position peaked at $12.4M in Q4 2022. 32 funds tracked by Wall St. Rank hold NFYS.WS as of Q1 2024.

Radcliffe Capital Management reported no remaining Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2024 after selling out during the quarter.
Radcliffe Capital Management sold 858,615 Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2024, an estimated $40.8K.
Radcliffe Capital Management first reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 9 quarters.
Radcliffe Capital Management's Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $12.4M in Q4 2022.
32 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2024.

Based on Radcliffe Capital Management's 13F filing for Q1 2024, filed 15 May 2024.